This past December, the FDA finalized its guidance on rare diseases with the publication Rare Diseases: Considerations for the Development of Drugs…

Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country differences, is exponentially…

I grew up in the Midwest — the middle child in a large family. We were each tagged with certain labels and expectations: the smart ones, the…

In this post-COVID era, our clients have experienced a culture shift — driven by remote work, digital transformation, accelerated innovation, and a…

Every horse race has a starting bell, a push to move as fast as possible, and a finish line. In many ways, the launch of a new drug can feel similar.…

Over the past 20 years, The NemetzGroup has been involved in the launch of more than 50 different drugs and has had input into the strategic…

There are many ways we introduce ourselves to make an impact and grab the attention of our audience. In our line of work, that might be what your…

“Gen Z professionals have a low tolerance for inefficiency and are not going to allow their boomer bosses to remain selective luddites.” That’s how…

It’s no secret that the last few years have been hard on just about everyone. COVID, climate change, political strife in the US and around the world……

When it comes to team performance and adherence to “best practices,” what works on paper or in a teambuilding workshop and what actually occurs are…